Sandu Pharmaceuticals Ltd has informed that the Board of Directors at their Meeting held on February 14, 2022 have approved incorporation of a wholly owned subsidiary of the Company.
As per regulatory filing, the name of the subsidiary is Sandu Phytoceuticals Private Limited or any other name as may be approved by Ministry of Corporate Affairs. Proposed Authorized Capital is Rs1 lakh only.
Further, the Incorporation of the wholly owned subsidiary will leverage the growth opportunities and will help the Company in becoming more broad based and focused, said company on Monday.
At around 11:30 AM, Sandu Pharmaceuticals was trading at Rs57.10 apiece down by Rs0.45 or 0.78% against its previous closing of Rs57.55 apiece on the BSE.
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.